-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
Shahi M, Katsakhyan L, Hopkins M, Allen-Rhoades W, Cepress MK, Langstraat C, Ishitani MB, Vang R, Ronnett BM, Xing D. Ovarian non-gestational placental site ...
-
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
-
A Mayo Clinic doctor explains and discusses undifferentiated pleomorphic sarcoma treatment options.
-
... . VID-20164076. Home; YouTube - Mayo Clinic Patient Visitor Guide - Arizona - Mayo Hospital. Fuel groundbreaking medical research!
-
The purpose of this study is to evaluate the challenges, behavioral patterns, and preferences of minority patient participation in clinical trials. Also, to ...
-
Kolberg C, Bogle J, DeJong MD, Deep N, Weisskopf P, Dornhoffer JR, Neff BA, Driscoll CLW, Carlson ML, Saoji AA. Impact of Vestibular Schwannoma Management ...
-
Andress B, Miller SA, Maus AD, Kemp JV, Bornhorst JA, Grebe SK, Algeciras-Schimnich A. Undetectable Serum Thyroglobulin in Patients with Differentiated ...
-
African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...
-
Huber JM, Wieland ML, Bornstein SL, Mauck KF, Szostek JH, Post JA, Wingo MT. Update in Outpatient General Internal Medicine: Practice-Changing Evidence ...